Zhang Bin, McGee Beth, Yamaoka Jennifer S, Guglielmone Hugo, Downes Katharine A, Minoldo Salvador, Jarchum Gustavo, Peyvandi Flora, de Bosch Norma B, Ruiz-Saez Arlette, Chatelain Bernard, Olpinski Marian, Bockenstedt Paula, Sperl Wolfgang, Kaufman Randal J, Nichols William C, Tuddenham Edward G D, Ginsburg David
Life Sciences Institute, Department of Internal Medicine, 210 Washtenaw Ave, Ann Arbor, MI 48109-0650, USA.
Blood. 2006 Mar 1;107(5):1903-7. doi: 10.1182/blood-2005-09-3620. Epub 2005 Nov 22.
Mutations in LMAN1 (ERGIC-53) or MCFD2 cause combined deficiency of factor V and factor VIII (F5F8D). LMAN1 and MCFD2 form a protein complex that functions as a cargo receptor ferrying FV and FVIII from the endoplasmic reticulum to the Golgi. In this study, we analyzed 10 previously reported and 10 new F5F8D families. Mutations in the LMAN1 or MCFD2 genes accounted for 15 of these families, including 3 alleles resulting in no LMAN1 mRNA accumulation. Combined with our previous reports, we have identified LMAN1 or MCFD2 mutations as the causes of F5F8D in 71 of 76 families. Among the 5 families in which no mutations were identified, 3 were due to misdiagnosis, with the remaining 2 likely carrying LMAN1 or MCFD2 mutations that were missed by direct sequencing. Our results suggest that mutations in LMAN1 and MCFD2 may account for all cases of F5F8D. Immunoprecipitation and Western blot analysis detected a low level of LMAN1-MCFD2 complex in lymphoblasts derived from patients with missense mutations in LMAN1 (C475R) or MCFD2 (I136T), suggesting that complete loss of the complex may not be required for clinically significant reduction in FV and FVIII.
LMAN1(内质网-高尔基体中间腔室蛋白53,ERGIC-53)或MCFD2的突变会导致凝血因子V和凝血因子VIII联合缺乏(F5F8D)。LMAN1和MCFD2形成一种蛋白复合物,作为货物受体将凝血因子V和凝血因子VIII从内质网转运至高尔基体。在本研究中,我们分析了10个先前报道的和10个新的F5F8D家系。LMAN1或MCFD2基因的突变在其中15个家系中被发现,包括3个导致LMAN1 mRNA无法积累的等位基因。结合我们之前的报道,我们已在76个家系中的71个家系中确定LMAN1或MCFD2突变是F5F8D的病因。在未发现突变的5个家系中,3个是由于误诊,其余2个可能携带直接测序遗漏的LMAN1或MCFD2突变。我们的结果表明,LMAN1和MCFD2的突变可能是所有F5F8D病例的病因。免疫沉淀和蛋白质印迹分析在源自LMAN1(C475R)或MCFD2(I136T)错义突变患者的淋巴母细胞中检测到低水平的LMAN1-MCFD2复合物,这表明复合物的完全缺失可能并非FV和FVIII临床显著降低所必需。